Growth Metrics

Travere Therapeutics (TVTX) Restructuring Costs (2016 - 2024)

Travere Therapeutics' Restructuring Costs history spans 4 years, with the latest figure at $1.4 million for Q4 2024.

  • For Q4 2024, Restructuring Costs fell 87.69% year-over-year to $1.4 million; the TTM value through Sep 2025 reached $1.4 million, down 88.71%, while the annual FY2024 figure was $2.4 million, 78.6% down from the prior year.
  • Restructuring Costs reached $1.4 million in Q4 2024 per TVTX's latest filing, up from $123000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $11.4 million in Q4 2023 to a low of $123000.0 in Q3 2024.